Engineering Cells Through Programmable Mechanical Forces
ForCell is developing a proprietary microfluidic platform that uses programmable mechanical compression to engineer, condition, and deliver molecules into clinically-relevant human cells.
For decades, cell manufacturing and gene editing have focused almost entirely on biochemical control. Yet, cells naturally exist in environments where physical forces continually influence their behaviour, function, and genome engineering capacity. By applying controlled mechanical force, ForCell introduces a more efficient, non-viral approach to gene editing, stem-cell processing, and cell therapy manufacturing.
Why ForCell?
In the bone marrow, blood stem cells experience constant mechanical forces from surrounding tissue and the skeleton. The moment these cells are removed for processing, expansion, or gene editing, many of those physical cues disappear.
ForCell introduces controlled mechanical inputs back into the workflow using programmable microfluidic compression. By giving researchers precise regulation over force magnitude, pressure, and exposure duration, our platform provides a controlled way to apply mechanical stimulation during cell processing, gene editing, and cell therapy manufacturing.
Platform Capabilities

Cell Engineering & Gene Editing
Workflows for mechanically assisted cell engineering and genome-editing applications.

Non-Viral Intracellular Delivery
Mechanical approaches to introducing molecules into clinically relevant cells.

Adaptive Membrane Response
Study and control cellular membrane mechanics and response.

Stem-Cell Processing
Mechanical conditioning for stem-cell processing and expansion workflows.

Cell & Nuclear Mechanics
Investigate cell mechanics, nuclear architecture and mechanobiology.
Funding & Strategic Support
Translational & Proof-of-Concept
Venture Building & Acceleration
Meet Our Dedicated Agents
Global Network & Collaborations
Working with leading clinical and research institutions to benchmark and validate ForCell technology across primary cell workflows.
Advancing the next generation of cell engineering
We work with academic, clinical and industry partners exploring cell engineering, gene editing and cell therapy manufacturing.
Contact the Team
Interested in evaluating the platform or exploring a partnership?
Get in touch to discuss collaboration opportunities and technology evaluation
















